サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1548075

ワクチンの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 222 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.42円
ワクチンの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 222 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ワクチン市場の世界需要は、2023年の1,274億1,000万米ドルから2032年には1,591億1,000万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは2.5%です。

ワクチンとは、特定の病気に対する免疫を作り出すことで、人々を病気から守る物質です。ワクチンには微生物の死骸や弱毒化したものが含まれており、これらの微生物は免疫系を刺激して抗体を産生させる。ほとんどのワクチンは注射、経鼻、経口で投与されます。免疫系を活性化したり刺激したりするために利用される戦略によって、ワクチンは不活化型、弱毒型、トキソイド型、サブユニット型、実験型、価数型、ヘテロ型、結合型などのタイプに分類されます。現在開発中で、まだ商業化されていないワクチンも多数あります。

市場力学

世界の撲滅目標と人口増加がワクチン市場の成長を牽引すると予測されています。毎年、推定200～300万人の子どもの死亡と60万人の成人の死亡がワクチン接種によって予防されています。それでもなお、毎年数百万人の命を奪っている病気が数多くあり、有効なワクチンがまだないため、新しい改良型ワクチンの研究開発が行われています。高所得国は世界のワクチン売上高の82％を占める主要なワクチン購入国です。しかし、ワクチンの浪費は市場収益に影響を与える大きな問題として認識されています。また、ワクチンを購入するための資金が不足している国もあれば、国家当局が十分に機能していないためにワクチン開発に必要なリソースや権限を持たない国もあるという懸念もあります。これはワクチンの将来的な実行可能性に影響します。成長に影響を与えるこれらの要因を評価するため、WHOは、ワクチン接種不足を測定し、対処するためのプログラムやパートナーを支援する一連のツールを開発し、様々な対策を講じています。

この調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、ワクチンの世界市場における各セグメントを包括的に評価することもできます。ワクチン産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

市場セグメンテーションでは、国別と地域別のセグメントに関する詳細なデータを提供することで、戦略担当者が各製品やサービスの対象層を特定し、今後のビジネス機会に役立てることができます。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるワクチン市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 ワクチン-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 ワクチンの世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • サブユニットワクチン（組み換えワクチン、結合型ワクチン、トキソイドワクチン）
  • 不活化ワクチン
  • 生ワクチン
  • mRNAワクチン
  • ウイルスベクターワクチン

第6章 世界のワクチン市場分析：投与経路別

  • 投与経路別概要
  • 実績データと予測データ
  • 投与経路別分析
  • 経口
  • 非経口
  • 経鼻

第7章 ワクチンの世界市場分析：適応疾患別

  • 適応疾患別概要
  • 実績データと予測データ
  • 適応疾患別分析
  • ウイルス性疾患（肝炎、インフルエンザ、HPV、MMR、ロタウイルス、帯状疱疹、COVID-19、その他）
  • 細菌ワクチン（髄膜炎菌感染症、肺炎球菌感染症、DPT、その他）
  • がんワクチン
  • アレルギーワクチン

第8章 世界のワクチン市場分析：年齢層別

  • 年齢層別概要
  • 実績データと予測データ
  • 年齢層別分析
  • 小児
  • 成人

第9章 ワクチンの世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 病院・小売薬局
  • 政府系サプライヤー
  • その他

第10章 ワクチンの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第11章 ワクチン企業の競合情勢

  • ワクチン市場の競合
  • パートナーシップ/提携/協定
  • 合併・買収
  • 新製品上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Serum Institute Of India Pvt. Ltd.
  • Seqirus
  • Sanofi
  • GSK Plc.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Moderna Inc.
  • Sinovac
  • BioNTech SE
  • AstraZeneca
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines) Market Sales By Geography (USD MN)
  • Inactivated Market Sales By Geography (USD MN)
  • Live Attenuated Market Sales By Geography (USD MN)
  • mRNA vaccines Market Sales By Geography (USD MN)
  • Viral vector vaccines Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Nasal Market Sales By Geography (USD MN)
  • Analysis By Disease Indication (USD MN)
  • Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Market Sales By Geography (USD MN)
  • Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Market Sales By Geography (USD MN)
  • Cancer Vaccines Market Sales By Geography (USD MN)
  • Allergy Vaccines Market Sales By Geography (USD MN)
  • Analysis By Age Group (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital & Retail Pharmacies Market Sales By Geography (USD MN)
  • Government Suppliers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Vaccine Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Vaccine Report
  • Market Research Process
  • Market Research Methodology
  • Global Vaccine Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Disease Indication
  • Market Attractiveness Analysis By Age Group
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines) Market Sales By Geography (USD MN)
  • Inactivated Market Sales By Geography (USD MN)
  • Live Attenuated Market Sales By Geography (USD MN)
  • mRNA vaccines Market Sales By Geography (USD MN)
  • Viral vector vaccines Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Nasal Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Indication (USD MN)
  • Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Market Sales By Geography (USD MN)
  • Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Market Sales By Geography (USD MN)
  • Cancer Vaccines Market Sales By Geography (USD MN)
  • Allergy Vaccines Market Sales By Geography (USD MN)
  • Global Market Analysis By Age Group (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital & Retail Pharmacies Market Sales By Geography (USD MN)
  • Government Suppliers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11211825

The global demand for Vaccine Market is presumed to reach the market size of nearly USD 159.11 Billion by 2032 from USD 127.41 Billion in 2023 with a CAGR of 2.5% under the study period 2024-2032.

Vaccines are the substance that protects people from diseases by producing immunity to a specific disease. It contains a dead or weakened version of microbes; these microbes stimulate immune system to produce antibodies. Most vaccines are given by injection, nasally, or by mouth. Depending on strategies utilised to activate or stimulate immune system,vaccines are classified into different types:inactivated, attenuated, toxoid, subunit, experimental, valence, heterotypic and conjugate. There are number of the vaccines under development and yet to commercialise.

MARKET DYNAMICS

Global eradication goals and population expansion are predicted to drive the growth of the vaccine market. Annually, an estimated 2-3 million child deaths and 600,000 adult deaths are prevented by vaccination. Still, there are many diseases that claim millions of lives yearly and for which effective vaccines are not yet available this is giving rise to research and development of the new and improved vaccine. High-income countries are major purchasers of vaccine constituting 82% of global vaccine sales. However, vaccine wastage is identified as a major problem to affect market revenue. There is also another concern that some countries have insufficient funds to buy vaccine while some countries don't have resource or mandate required to conduct the vaccine development due to poor functioning national authorities. This affects the future viability of the vaccine. To assess these factors affecting growth, WHO is taking various measures by developing a set of tools to support programmes and partners to measure and address under-vaccination.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Vaccine. The growth and trends of Vaccine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Vaccine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines)
  • Inactivated
  • Live Attenuated
  • mRNA vaccines
  • Viral vector vaccines

By Route of Administration

  • Oral
  • Parenteral
  • Nasal

By Disease Indication

  • Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others)
  • Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others)
  • Cancer Vaccines
  • Allergy Vaccines

By Age Group

  • Pediatric
  • Adult

By Distribution Channel

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Vaccine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Vaccine market include Serum Institute Of India Pvt. Ltd., Seqirus, Sanofi, GSK Plc., Merck & Co. Inc., Pfizer Inc., Moderna Inc., Sinovac, BioNTech SE, AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. VACCINE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Disease Indication
    • 3.7.4 Market Attractiveness Analysis By Age Group
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL VACCINE MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Type
  • 5.4. Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines) Historic and Forecast Sales By Regions
  • 5.5. Inactivated Historic and Forecast Sales By Regions
  • 5.6. Live Attenuated Historic and Forecast Sales By Regions
  • 5.7. mRNA vaccines Historic and Forecast Sales By Regions
  • 5.8. Viral vector vaccines Historic and Forecast Sales By Regions

6. GLOBAL VACCINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route of Administration
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Route of Administration
  • 6.4. Oral Historic and Forecast Sales By Regions
  • 6.5. Parenteral Historic and Forecast Sales By Regions
  • 6.6. Nasal Historic and Forecast Sales By Regions

7. GLOBAL VACCINE MARKET ANALYSIS BY DISEASE INDICATION

  • 7.1. Overview By Disease Indication
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Disease Indication
  • 7.4. Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Historic and Forecast Sales By Regions
  • 7.5. Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Historic and Forecast Sales By Regions
  • 7.6. Cancer Vaccines Historic and Forecast Sales By Regions
  • 7.7. Allergy Vaccines Historic and Forecast Sales By Regions

8. GLOBAL VACCINE MARKET ANALYSIS BY AGE GROUP

  • 8.1. Overview By Age Group
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Age Group
  • 8.4. Pediatric Historic and Forecast Sales By Regions
  • 8.5. Adult Historic and Forecast Sales By Regions

9. GLOBAL VACCINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1. Overview By Distribution Channel
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By Distribution Channel
  • 9.4. Hospital & Retail Pharmacies Historic and Forecast Sales By Regions
  • 9.5. Government Suppliers Historic and Forecast Sales By Regions
  • 9.6. Others Historic and Forecast Sales By Regions

10. GLOBAL VACCINE MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE VACCINE COMPANIES

  • 11.1. Vaccine Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF VACCINE INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Serum Institute Of India Pvt. Ltd.
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Seqirus
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Sanofi
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. GSK Plc.
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Merck & Co. Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Pfizer Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Moderna Inc.
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Sinovac
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. BioNTech SE
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. AstraZeneca
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies